Literature DB >> 12552353

Improved detection of splenosis in patients with haematological disorders: the role of combined transmission-emission tomography.

Marius Horger1, Susanne Martina Eschmann, Claudia Lengerke, C D Claussen, Christina Pfannenberg, Roland Bares.   

Abstract

The purpose of this study was to evaluate the use of combined transmission and emission tomography (TET) for correct localisation of heterotopic splenic tissue and differentiation of splenosis from other masses. The TET technique comprises the fusion of SPET and CT data obtained using the same imaging device to allow perfect overlap of anatomical and functional images. TET was performed in seven patients who either had haematological disorders and relapsing anaemia or thrombocytopenia after splenectomy or were under immunosuppression for different reasons. These patients presented 20 equivocal lesions on CT or MRI. Presence of splenic tissue was investigated using technetium-99m labelled colloids or heat-damaged red blood cells. Findings of spleen scintigraphy, TET and CT or MRI were compared with respect to localisation of splenosis and correct classification of lesions by CT or MRI. Histological validation was achieved by surgery or biopsy in all cases. All 20 lesions demonstrated by CT or MRI were correctly classified by TET as splenosis. Three additional lesions initially overlooked by CT or MRI could be detected. Diagnostic relevance was highest for intrahepatic, intrapulmonary or pleural splenic implants. It is concluded that TET allows exact localisation of heterotopic splenic tissue in patients with suspected splenosis.

Entities:  

Mesh:

Year:  2002        PMID: 12552353     DOI: 10.1007/s00259-002-1043-7

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  15 in total

1.  Intrathoracic splenosis: evaluation by 99mTc-labelled heat-denatured erythrocyte SPECT/CT.

Authors:  Cinzia Crivellaro; Grazia Cabrini; Emma Gay; Roberto Sara; Claudio Rossetti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-11-11       Impact factor: 9.236

2.  Hybrid SPECT/CT: a new era for SPECT imaging?

Authors:  Orazio Schillaci
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-05       Impact factor: 9.236

3.  Localization of splenosis using 99mTc-damaged red blood cell SPECT/CT and intraoperative gamma probe measurements.

Authors:  Rolando Alvarez; Kathleen M Diehl; Anca Avram; Richard Brown; Morand Piert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-04-25       Impact factor: 9.236

Review 4.  Technological development and advances in single-photon emission computed tomography/computed tomography.

Authors:  Youngho Seo; Carina Mari; Bruce H Hasegawa
Journal:  Semin Nucl Med       Date:  2008-05       Impact factor: 4.446

Review 5.  A review on the clinical uses of SPECT/CT.

Authors:  Giuliano Mariani; Laura Bruselli; Torsten Kuwert; Edmund E Kim; Albert Flotats; Ora Israel; Maurizio Dondi; Naoyuki Watanabe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-02-25       Impact factor: 9.236

6.  Chronic Abdominal Pain from Disseminated Splenosis.

Authors:  Michael A Santos
Journal:  J Gen Intern Med       Date:  2018-06       Impact factor: 5.128

7.  Intrahepatic splenosis mimicking hepatoma.

Authors:  Haihua Yu; Lijian Xia; Tao Li; Minjie Ju; Liang Liu; Zhiquan Wu; Zhaoyou Tang
Journal:  BMJ Case Rep       Date:  2009-02-02

Review 8.  Abdominal and pelvic splenosis: atypical findings, pitfalls, and mimics.

Authors:  Travis Smoot; Jonathan Revels; Moataz Soliman; Peter Liu; Christine O Menias; Hero H Hussain; Hatice Savas; Ayman H Gaballah
Journal:  Abdom Radiol (NY)       Date:  2022-01-25

Review 9.  Peritoneal disease: key imaging findings that help in the differential diagnosis.

Authors:  Nuno M F Campos; Vânia Almeida; Luís Curvo Semedo
Journal:  Br J Radiol       Date:  2021-11-23       Impact factor: 3.039

Review 10.  Acquisition parameters for oncologic imaging with a new SPECT/multislice CT scanner.

Authors:  Rodolfo Núñez; William D Erwin; Richard E Wendt; Anne Stachowiak; Martha Mar; Donna Stevens; John E Madewell; Henry W Yeung; Homer A Macapinlac
Journal:  Mol Imaging Biol       Date:  2010-01-05       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.